Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas

Decera Clinical Education Oncology Podcast · Aug 15, 2025 · 29m

In this episode, Dr. Daniel Morgensztern and Dr. Jonathan Strosberg discuss the emerging role of DLL3-targeted agents in the management of extrapulmonary neuroendocrine carcinomas, including:

The clinical implications of using DLL3 as a therapeutic target

The impact of emerging DLL3-targeted therapies on evolving treatment paradigms

How to incorporate DLL3-based treatments into clinical practice

Presenters:

Daniel Morgensztern, MD

Professor of Medicine

Clinical Director of Thoracic Oncology

Washington University School of Medicine

St Louis, Missouri

Jonathan Strosberg, MD

Professor

Department…